87686-74-6 (8-P-COUMAROYL-HARPAGIDE,8-p-coumaroyl-harpagide)

8-P-COUMAROYL-HARPAGIDE;8-P-COUMAROYLHARPAGIDE;(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-[[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-7-methylcyclopenta[c]pyran-1-yl β-D-glucopyranoside (ACI);β-D-Glucopyranoside, (1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-[[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]oxy]-7-methylcyclopenta[c]pyran-1-yl (9CI);β-D-Glucopyranoside, 1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-[[3-(4-hydroxyphenyl)-1-oxo-2-propenyl]oxy]-7-methylcyclopenta[c]pyran-1-yl, [1S-[1α,4aα,5α,7α(E),7aα]]- (ZCI);8-O-(4-Hydroxycinnamoyl)harpagide;8-O-(p-Coumaroyl)harpagide;8-O-p-Hydroxy-E-cinnamoylharpagide;[4a,5-Dihydroxy-7-methyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] 3-(4-hydroxyphenyl)prop-2-enoate;87686-74-6;CHEMBL513852;8-coumaroylharpagide;[(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate;8-O-4-Hydroxycinnamoylharpagide, >=95% (LC/MS-ELSD);8-O-(p-Coumaroyl)-harpagide;(1S,4AS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl (E)-3-(4-hydroxyphenyl)acrylate;

MFCD08460266

AZKQDXZMKREFDY-CBLWINFVSA-N

1S/C24H30O12/c1-23(36-16(28)7-4-12-2-5-13(26)6-3-12)10-15(27)24(32)8-9-33-22(20(23)24)35-21-19(31)18(30)17(29)14(11-25)34-21/h2-9,14-15,17-22,25-27,29-32H,10-11H2,1H3/b7-4+/t14-,15-,17-,18+,19-,20-,21+,22+,23+,24-/m1/s1

O([C@]1(C[C@@H](O)[C@]2([C@@H]1[C@@H](OC=C2)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)C(=O)/C=C/C1C=CC(O)=CC=1